Thermo Fisher Scientific | TMO - Ebitda

Stock Price
469.71
Daily Change
3.01 0.64%
Monthly
-4.29%
Yearly
10.72%
Q2 Forecast
459.66

Thermo Fisher Scientific reported $2.7B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Agilent USD 540M 74M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Bio Techne USD 103.42M 7.47M Dec/2025
Bio-Rad Laboratories USD -374.6M 841.8M Sep/2025
Boston Scientific USD 1.16B 213M Dec/2025
Bruker USD 211.6M 207.4M Dec/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Danaher USD 1.92B 204M Mar/2026
Dentsply International USD 135M 32M Dec/2025
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
General Electric Aerospace USD 2.84B 568M Mar/2026
Henry Schein USD 291M 4M Dec/2025
Illumina USD 332M 12M Sep/2025
Intuitive Surgical USD 1.09B 165.5M Dec/2025
IQVIA Holdings USD 1.05B 97M Dec/2025
Laboratory Of America USD 588.1M 24.1M Dec/2025
Medtronic USD 2.93B 482M Dec/2025
Mettler Toledo International USD 322.64M 26.75M Sep/2025
Myriad Genetics USD 14.3M 4M Dec/2025
Olympus JPY 45.72B 4.58B Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Quest Diagnostics USD 557M 20M Mar/2026
Repligen USD 39.54M 3.61M Dec/2025
Revvity USD 248.91M 48.52M Dec/2025
Stryker USD 1.67B 206M Sep/2025
Thermo Fisher Scientific USD 2.7B 464M Mar/2026
Veracyte USD 42.31M 2.58M Dec/2025
Waters USD 380.97M 85.83M Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025